Claudia Seikrit - Publications

Serum levels of guanidinylated YB-1 indicate active lupus nephritis.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: August 26, 2026

Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury.

Journal: Nature reviews. Nephrology

Published: July 09, 2026

Beyond galactose-deficient IgA1: reconsidering IgA2 as a pathogenic driver in IgA nephropathy.

Journal: Kidney international

Published: February 24, 2026

Long-term real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors.

Journal: Clinical kidney journal

Published: February 15, 2026

Differing effects of Nefecon and Sparsentan in a patient with recurrent IgA nephropathy post-kidney transplantation.

Journal: Clinical kidney journal

Published: February 14, 2026

Individualised treatment effects of corticosteroids in IgA nephropathy.

Journal: EBioMedicine

Published: December 01, 2025

First real-world evidence of sparsentan efficacy in patients with IgA nephropathy treated with SGLT2 inhibitors.

Journal: Clinical kidney journal

Published: August 09, 2024

Corticosteroids in Patients With IgA Nephropathy: Is the Lower the Better?

Journal: Kidney international reports

Published: July 31, 2024

Long-term outcomes of patients with IgA nephropathy in the German CKD cohort.

Journal: Clinical kidney journal

Published: June 10, 2024

IgA nephropathy.

Journal: Nature reviews. Disease primers

Published: October 26, 2023

Lineage tracing reveals transient phenotypic adaptation of tubular cells during acute kidney injury.

Journal: iScience

Published: September 02, 2023

Novel agents for treating IgA nephropathy.

Journal: Current opinion in nephrology and hypertension

Published: June 29, 2023